Skip to content
Legal Smart Journal

Law. Science. Health. Society.
Real questions. Evidence-based answers.

EN/SR
Health·6 min read

A Spoonful of Plastic in the Brain? What the Evidence Really Shows

The 2025 finding travelled the world as a single vivid image. The study behind it is more interesting, more uncertain and more useful than the image suggests.

SD
By Science Desk
2 October 2026
Illustration, not a photograph of the events described.
Illustration, not a photograph of the events described.

The Short Answer

A 2025 study in Nature Medicine measured plastic particles in human brain tissue and found higher levels in recent samples. The “spoonful” was a commentators' calculation, the measurement method is contested, and the study cannot show that plastic harms the brain.

The claim

In February 2025, a widely shared claim held that the average human brain contains about a spoonful of plastic. The figure appeared in headlines, in television segments and in social media posts illustrated with a plastic spoon beside a brain.

The claim comes from a real study, published in Nature Medicine on 3 February 2025 by a team led by the toxicologist Matthew Campen at the University of New Mexico. The spoon, however, was not in the study. It came from commentators who multiplied the reported concentration by the weight of an average brain. That step is where the story begins to drift from the evidence.

What the study found

The researchers analysed tissue from people who had died and undergone autopsy at the New Mexico Office of the Medical Investigator. There were two groups, from 2016 and 2024, with 20 to 28 people in each depending on the organ. From each person they took a single sample of liver, of kidney and of brain, the brain samples coming from the frontal cortex. They also examined older brain samples, collected between 1997 and 2013, from repositories on the US East Coast, and brain tissue from twelve people with a documented diagnosis of dementia.

The headline numbers were these.

Tissue Median concentration reported
Brain, 1997–2013 about 1,250 µg per gram
Brain, 2016 about 3,350 µg per gram
Brain, 2024 about 4,900 µg per gram
Liver, 2024 about 430 µg per gram
Kidney, 2024 about 400 µg per gram
Brain, dementia cases (2019–2024) about 26,000 µg per gram

A concentration of around 4,900 micrograms per gram is roughly half a percent of tissue by weight. That is the origin of the spoon.

The researchers reported that most of the plastic was polyethylene, the polymer used in bags, films and bottle caps. Under the electron microscope, the particles appeared mostly as tiny shard-like fragments at the nanoscale. Concentrations did not vary with age, sex, ethnicity or cause of death, but did differ by year of death.

How they found it

The method matters, because most of the later debate concerns it.

The main technique was pyrolysis gas chromatography–mass spectrometry. A tissue sample is first dissolved chemically. What remains is heated until any polymers break into smaller molecules, which are separated and identified. From the pattern of those molecules, the instrument estimates how much of each type of plastic was present. It does not count particles or look at them. It infers a mass from a chemical signature.

Two other techniques, infrared spectroscopy and electron microscopy, were used to confirm that particles were present and to describe their shape.

The authors were open about some limits. They took only one sample from each organ for each person, so how plastic is distributed within an organ remains unknown. And both laboratories involved saw variation of about 25 percent between repeated measurements of the same sample.

What the study cannot show

Three limits matter more than any others.

First, the study is cross-sectional and based on autopsies. It measured tissue at one moment after death. It cannot show how plastic entered the brain, how long it stayed or whether it was cleared.

Second, the dementia finding is an association in a small sample. Twelve people with dementia had higher measured concentrations than the other groups. That is consistent with plastic contributing to disease. It is equally consistent with disease changing how the brain accumulates or clears particles, with other factors affecting both, or with measurement differences between samples. The study design cannot distinguish between these possibilities.

Third, and most important, the absolute numbers depend entirely on the measurement method being accurate in brain tissue. That is exactly what was questioned.

Where scientists disagree

On 12 March 2025, Germany’s Federal Institute for Risk Assessment (BfR) published an assessment. It described the study as noteworthy and raised several technical concerns. Samples had contact with plastic materials during autopsy and processing, and contamination controls were not documented in enough detail. Some spectral data were missing. Most significantly, brain tissue is roughly 60 percent fat on a dry-weight basis, and certain fatty compounds break down under heat into molecules similar to those produced by polyethylene. “False and misinterpreted signals that would lead to overestimations of exposure cannot be ruled out,” the institute concluded.

Other scientists noted that the reported brain concentrations exceeded those measured in some samples of sewage sludge, which they considered implausible. Duplicated images were found in the supplementary material; the authors described the error as clerical and corrected it in March 2025. In November 2025, Nature Medicine published a formal critique of the paper, with a reply from the authors.

In September 2026, a group of Polish researchers writing in Particle and Fibre Toxicology examined the interference problem directly. They reported that standard chemical digestion of brain tissue can leave behind insoluble calcium and zinc salts of fatty acids — in effect, soaps — whose spectra resemble those of plastics. They proposed a modified preparation method to remove them.

None of this shows that the original study was wrong. It shows that its concentrations could be overestimated, possibly substantially, and that the method needs refinement before brain measurements can be compared reliably.

What other research says

The presence of micro- and nanoplastics in human tissue does not rest on a single study. Different groups, using different methods, have reported particles in blood, placenta, lung tissue and arterial plaque.

The most significant clinical study so far appeared in the New England Journal of Medicine in March 2024. Researchers led by Raffaele Marfella in Naples analysed plaque removed from the carotid arteries of 257 patients who completed follow-up. Polyethylene was detected in the plaque of 150 of them, about 58 percent. Over an average of roughly three years, those patients had about four and a half times the risk of heart attack, stroke or death from any cause compared with patients without detectable plastic.

This is a strong association from a well-designed observational study. It is still an association. Patients with plastic in their plaque may have differed in diet, occupation, income, smoking or exposure to other pollutants in ways the study could not fully measure. The authors acknowledged this.

Laboratory and animal studies suggest possible mechanisms, including inflammation and oxidative stress. They often use doses and particle types whose relevance to everyday human exposure is uncertain.

The World Health Organization’s 2022 review concluded that the available evidence was insufficient to determine the risk that micro- and nanoplastics pose to human health, and called for better research and standardised methods. Nothing published since has overturned that conclusion.

What we know today

Micro- and nanoplastics are present in human tissue, including the brain. That is supported by several independent lines of evidence.

How much is present in the brain is not reliably known. The 2025 figures may be too high.

Whether concentrations are rising over time is suggested by the 2025 data and is plausible given rising plastic production. It needs confirmation with validated methods.

Whether plastics in the body cause disease is not established. One major study links plastic in arterial plaque to cardiovascular events. The dementia association rests on twelve cases.

Whether current exposure is harmless is also not established.

What needs to be studied next

The next steps are unglamorous. Laboratories need agreed methods for preparing tissue, with controls for contamination and for fats. Different laboratories should measure the same samples and compare results. Studies need to follow living people over time, measuring exposure before illness appears rather than after death. And research needs to identify where most human exposure comes from, because that is what determines what can be reduced.

Regulators have not waited for all of this. The European Union has restricted microplastics deliberately added to products since October 2023 under Regulation (EU) 2023/2055, an approach based on precaution rather than proven harm. Negotiations on a global plastics treaty, begun in 2022, had not produced an agreement by mid-2026.

The spoon was never in the data. What the data do show is that plastic reaches our organs, that measuring it accurately is harder than it first appeared, and that the most important questions about its effects are still open. We know more than we did before the study. We do not yet know what it means for our health.

Sources: Nihart A. J. et al., “Bioaccumulation of microplastics in decedent human brains”, Nature Medicine (3 Feb 2025), with Author Correction (31 Mar 2025) and Matters Arising (13 Nov 2025) · BfR Communication No. 056/2025 (12 Mar 2025) · Dzierżyński E. et al., Particle and Fibre Toxicology (4 Sep 2026) · Marfella R. et al., NEJM 390:900–910 (2024) · WHO, Dietary and inhalation exposure to nano- and microplastic particles (2022) · Commission Regulation (EU) 2023/2055 · UNEP INC session records (2025–2026).

BfR dementia association measurement error microplastics in the brain nanoplastics Nature Medicine study NEJM carotid plaque study pyrolysis GC-MS scientific uncertainty WHO